Keytruda + chemotherapy improved overall survival versus chemotherapy alone as for advanced malignant pleural mesothelioma
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Results reinforce commitment to next-generation oral SERD development programme
This association between the two esteemed organizations allows Medvarsity to significantly – and positively – impact healthcare education
New mass spectrometry instrument and consumables launch during IMSC 2022
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
Subscribe To Our Newsletter & Stay Updated